BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34512307)

  • 1. CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment.
    Karami A; Darreh-Shori T; Schultzberg M; Eriksdotter M
    Front Aging Neurosci; 2021; 13():704583. PubMed ID: 34512307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer's Disease.
    Karami A; Eriksdotter M; Kadir A; Almkvist O; Nordberg A; Darreh-Shori T
    Front Mol Neurosci; 2019; 12():239. PubMed ID: 31680850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.
    Vijayaraghavan S; Karami A; Aeinehband S; Behbahani H; Grandien A; Nilsson B; Ekdahl KN; Lindblom RP; Piehl F; Darreh-Shori T
    PLoS One; 2013; 8(6):e65936. PubMed ID: 23840379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
    DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
    Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic Displays of Cholinergic Enzymes Associate With Markers of Inflammation, Neurofibrillary Tangles, and Neurodegeneration in Pre- and Early Symptomatic Dementia Subjects.
    Teitsdottir UD; Darreh-Shori T; Lund SH; Jonsdottir MK; Snaedal J; Petersen PH
    Front Aging Neurosci; 2022; 14():876019. PubMed ID: 35693340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid cholinergic biomarkers are associated with postoperative delirium in elderly patients undergoing Total hip/knee replacement: a prospective cohort study.
    Lin X; Tang J; Liu C; Li X; Cao X; Wang B; Dong R; Xu W; Yu X; Wang M; Bi Y
    BMC Anesthesiol; 2020 Sep; 20(1):246. PubMed ID: 32988381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
    Karami A; Eyjolfsdottir H; Vijayaraghavan S; Lind G; Almqvist P; Kadir A; Linderoth B; Andreasen N; Blennow K; Wall A; Westman E; Ferreira D; Kristoffersen Wiberg M; Wahlund LO; Seiger Å; Nordberg A; Wahlberg L; Darreh-Shori T; Eriksdotter M
    Alzheimers Dement; 2015 Nov; 11(11):1316-28. PubMed ID: 25676388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology.
    Ikonomovic MD; Mufson EJ; Wuu J; Cochran EJ; Bennett DA; DeKosky ST
    J Alzheimers Dis; 2003 Feb; 5(1):39-48. PubMed ID: 12590165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature.
    Frankfort SV; Tulner LR; van Campen JP; Verbeek MM; Jansen RW; Beijnen JH
    Curr Clin Pharmacol; 2008 May; 3(2):123-31. PubMed ID: 18700307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
    Benedet AL; Milà-Alomà M; Vrillon A; Ashton NJ; Pascoal TA; Lussier F; Karikari TK; Hourregue C; Cognat E; Dumurgier J; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Salvadó G; Shekari M; Operto G; Gispert JD; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Zimmer ER; Zetterberg H; Molinuevo JL; Paquet C; Rosa-Neto P; Blennow K; Suárez-Calvet M;
    JAMA Neurol; 2021 Dec; 78(12):1471-1483. PubMed ID: 34661615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.
    Ikonomovic MD; Klunk WE; Abrahamson EE; Wuu J; Mathis CA; Scheff SW; Mufson EJ; DeKosky ST
    Neurology; 2011 Jul; 77(1):39-47. PubMed ID: 21700583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
    J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.
    Maccioni RB; Lavados M; Guillón M; Mujica C; Bosch R; Farías G; Fuentes P
    Neurobiol Aging; 2006 Feb; 27(2):237-44. PubMed ID: 16399209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
    Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
    Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.
    Johansson P; Almqvist EG; Johansson JO; Mattsson N; Andreasson U; Hansson O; Wallin A; Blennow K; Zetterberg H; Svensson J
    PLoS One; 2013; 8(11):e81989. PubMed ID: 24312390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease.
    Ikonomovic MD; Mufson EJ; Wuu J; Bennett DA; DeKosky ST
    Arch Neurol; 2005 Mar; 62(3):425-30. PubMed ID: 15767507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition.
    Cullen NC; Mälarstig AN; Stomrud E; Hansson O; Mattsson-Carlgren N
    Sci Rep; 2021 Jan; 11(1):1965. PubMed ID: 33479445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.